Align 4-aminobutyrate aminotransferase GabT; 5-aminovalerate transaminase; GABA aminotransferase; GABA-AT; Gamma-amino-N-butyrate transaminase; GABA transaminase; Glutamate:succinic semialdehyde transaminase; L-AIBAT; EC 2.6.1.19; EC 2.6.1.48 (characterized)
to candidate PP_4223 PP_4223 diaminobutyrate-2-oxoglutarate transaminase
Query= SwissProt::P22256 (426 letters) >FitnessBrowser__Putida:PP_4223 Length = 452 Score = 200 bits (508), Expect = 8e-56 Identities = 144/434 (33%), Positives = 215/434 (49%), Gaps = 34/434 (7%) Query: 3 SNKELMQRRSQ------AIPRGVGQIHPIFADRAENCRVWDVEGREYLDFAGGIAVLNTG 56 ++ L+QR+ Q + PR + P+ RA V DVEGR+++D G L G Sbjct: 9 TDSPLLQRQQQQESNARSYPRRI----PLALRRARGIHVEDVEGRQFIDCLAGAGTLALG 64 Query: 57 HLHPKVVAAVEAQL--KKLSHTCFQVLAYEPYL--ELCEIMNQKVPGDFAKKTLLVTTGS 112 H HP VV A++ L + HT + +L I+ + + + AK TG+ Sbjct: 65 HNHPVVVEAIQRVLADELPLHTLDLTTPVKDRFVQDLFGILPEALRRE-AKVQFCGPTGT 123 Query: 113 EAVENAVKIARAATKRSGTIAFSGAYHGRTHYTLALTGKVNPYSAGMGLMPGHVYRALYP 172 +AVE A+K+ R AT RS +AF GAYHG + L L G P L+ V YP Sbjct: 124 DAVEAALKLVRTATGRSTVLAFQGAYHGMSQGALNLMGSHGPKQPLGALLGNGVQFMPYP 183 Query: 173 ----CPLHGISEDDAIASIHRIFKNDAAPED----IAAIVIEPVQGEGGFYASSPAFMQR 224 CP E A++H + PE AA+++E VQGEGG + +++ Sbjct: 184 YDYRCPFGLGGEAGVKANLHYLENLLLDPESGVPLPAAVILEVVQGEGGVVPADIEWLKG 243 Query: 225 LRALCDEHGIMLIADEVQSGAGRTGTLFAMEQMGVAPDLTTFAKSIAGGFPLAGVTGRAE 284 +R + ++ G+ LI DE+QSG RTG +FA E G+ PD+ T +K+I G PLA V R + Sbjct: 244 VRRITEQAGVALIVDEIQSGFARTGRMFAFEHAGIVPDVVTLSKAIGGSLPLAVVVYR-D 302 Query: 285 VMDAVAPGGLGGTYAGNPIACVAALEVLKVFEQENLLQKANDLGQKLKDGLLAIAEKHPE 344 +D PG GT+ GN +A A V+ + L + A +GQ+L+ L + +P+ Sbjct: 303 WLDTWKPGAHAGTFRGNQMAMAAGSAVINYLVEHRLAEHAEAMGQRLRGHLQRLQRDYPQ 362 Query: 345 IGDVRGLGAMIAIELFEDGDHNKPDA--------KLTAEIVARARDKGLILLSCGPYYNV 396 +GD+RG G M+ +EL + +PDA L ++ +GLIL G + V Sbjct: 363 LGDIRGRGLMLGVELVD--PQGQPDALGHPPANRDLAPKVQRECLKRGLILELGGRHGAV 420 Query: 397 LRILVPLTIEDAQI 410 +R L PL I QI Sbjct: 421 VRFLPPLIISAEQI 434 Lambda K H 0.320 0.137 0.401 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 500 Number of extensions: 16 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 426 Length of database: 452 Length adjustment: 32 Effective length of query: 394 Effective length of database: 420 Effective search space: 165480 Effective search space used: 165480 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 51 (24.3 bits)
This GapMind analysis is from Jul 25 2024. The underlying query database was built on Jul 25 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory